On January 4, 2024, the 2023 Straight Flush Annual List of Listed Companies was officially announced!
Shanghai Medicilon Biomedical Co., Ltd. (hereinafter referred to as "Medicilon") stood out from more than 1,800 listed companies that settled in the Flush Enterprise and won the "Investment Elite Award"!
The "Annual List of Straight Flush Listed Companies" is a comprehensive evaluation of Straight Flush based on multi-dimensional data such as enterprise account data (fans, articles, interactions, etc.), IR activities (live roadshow broadcasts, column dialogues, research and investment customs, etc.), * and topic popularity. The number of participants has exceeded 3 million, and the number of votes has exceeded 18 million, and the fierce competition highlights the gold content and influence of the selection.
Straight Flush "Enterprise Account" is an authoritative and well-known communication platform between listed companies and investors. Since its entry, Medicilon has served as an effective communication bridge between the company and investors, showing the company's development direction and operating results to the market, and sharing technical experience and in-depth insights in the field of biomedical preclinical research and development. Medicilon relies on a one-stop biomedical preclinical R&D service platform and its high-quality content to actively interact with investors, and has established a close benign information communication channel with the capital market to efficiently achieve accurate access to value information.
Honor spurs the line, forge ahead. Winning the "Investment Elite Award" this time fully demonstrates the high recognition and support of the capital market and investors for Medicilon in corporate governance, R&D and innovation, investor relations, etc. Medicilon will continue to increase scientific and technological innovation, empower new drug research and development, improve the investor relations service matrix, better realize the benign interaction with the capital market, and create a "new business card" in the capital market!